跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 22,611 条关于
“CHO Plus”
全部
22,611
临床试验
15,403
药物
1,583
机构
1,446
资讯
4,179
去年
CHO Plus Secures $10.4M BARDA Contract to Develop Cell Lines for Filovirus Monoclonal Antibody Production
去年
CHO Plus Secures U.S. Patent for Engineered Yeast Cell Technology to Boost Protein Production
去年
Asimov Expands Strategic Partnerships to Accelerate Biologics Development Through CHO Edge Platform
去年
Yale Team Awarded $76M NIH Grant to Study Schizophrenia Risk in Youth
去年
WuXi Biologics Launches WuXia293Stable Platform to Address Manufacturing Challenges for Complex Biologics
2年前
FDA Approves Lazertinib Plus Amivantamab for First-Line EGFR-Mutated NSCLC
9个月前
Chitose Laboratory and Fujifilm Biosciences Form Strategic Alliance to Advance Biopharmaceutical Manufacturing
去年
Talazoparib Plus Enzalutamide Demonstrates Superior Outcomes in mCRPC Compared to Other PARP Inhibitor Combinations
2年前
RYBREVANT® Plus Lazertinib Shows Significant PFS Improvement in EGFR-Mutated NSCLC
去年
Nivolumab Plus AVD Prolongs PFS in Advanced Hodgkin Lymphoma
第 1 页,共 418 页
上一页
下一页